Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the radiographic and clinical outcomes of spinal fusion following use of Allosync Expand and autograft bone graft.


Clinical Trial Description

This is a single site, prospective study with patients selected as study subjects from the Investigator's standard patient population who fulfill the Inclusion/Exclusion Criteria and agree to participate in the study. The study surgery is standard of care, with patients identified as requiring surgery prior to enrollment. The study surgery is lumbar posterior fixation with supplemental posterolateral fusion at from 1 to 3 levels. One side of the posterolateral fusion will be Allosync Expand (utilizing the BMA Angel kit to hydrate) and the other side to autograft bone (control). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06415110
Study type Observational
Source Research Source
Contact
Status Enrolling by invitation
Phase
Start date May 2024
Completion date May 2027

See also
  Status Clinical Trial Phase
Suspended NCT03381677 - Pedicle Osteotomy for Stenosis Trial N/A
Terminated NCT02704689 - AccuLIF® PROSPECTIVE PATIENT OUTCOMES STUDY N/A
Completed NCT03928041 - A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced Interbody Cages in the Lumbar Spine N/A
Completed NCT01944345 - Patient Registry to Observe Outcomes Following Implantation of the VariLift Interbody Fusion Device N/A